key: cord-1008199-2cj92ams authors: Trehanpati, N.; Singh, R.; Bajpai, M.; Yadav, P.; Maheshwari, A.; Kumar, S.; Agrawal, S.; Kumar, J.; Islam, M.; Maras, J. S.; Ramakrishna, G.; Sarin, S. K. title: Sustained expression of inflammatory monocytes and activated T cells in COVID-19 patients and recovered convalescent plasma donors date: 2020-11-18 journal: nan DOI: 10.1101/2020.11.17.20233668 sha: 1cd9846fbded0d84bbebb8da8508c07cbe43719c doc_id: 1008199 cord_uid: 2cj92ams Intense monocyte activation and infiltration into the target tissues is the main mechanism of lung injury in SARS CoV2 infection. A reduction in the degree and nature of such cellular responses is expected following recovery. We aimed to investigate the immune responses in severe Covid-19 patients and recovered patients. Methods: Severe COVID-19 patients (n=34) at Lok Nayak Hospital, New Delhi and COVID-19 recovered patients (n=15) from mild disease and considered for convalescent plasma (COPLA) donation at Institute of Liver and Biliary Sciences (ILBS), New Delhi were recruited. We performed a multiplex cytokine bead assay in plasma and detailed multicolour flow cytometric analysis in peripheral blood of both groups and outcomes were compared in both groups and with healthy controls (n=10). Results: A significant increase in inflammatory markers [MIP1-a, MIP3a, MCP1, MIF, MMP12, ITAC, VEGF-A, and leptin] was observed in severe patients. Non-survivors additionally showed increased IL-6 levels. Despite the sustained expression of MIPs, the recovered patients showed a surge in MCSF and IL-18 levels. Both the groups had increased CCR2, CX3CR1 positive monocytes, low CD8 T cells, APRIL and BAFFR+ve B cells compared with healthy subjects. In conclusion, patients who have recovered and considered for COPLA donations still have compromised immunity with sustained expression of inflammatory monocytes and activated T cells. Intense monocyte activation and infiltration into the target tissues is the main mechanism of lung injury in SARS CoV2 infection. A reduction in the degree and nature of such cellular responses is expected following recovery. We aimed to investigate the immune responses in severe Covid-19 patients and recovered patients. Methods: Severe COVID-19 patients (n=34) at Lok Nayak Hospital, New Delhi and COVID-19 recovered patients (n=15) from mild disease and considered for convalescent plasma (COPLA) donation at Institute of Liver and Biliary Sciences (ILBS), New Delhi were recruited. We performed a multiplex cytokine bead assay in plasma and detailed multicolour flow cytometric analysis in peripheral blood of both groups and outcomes were compared in both groups and with healthy controls All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. There is no targeted drug therapy for COVID-19 available at present, although some studies have indicated benefits with, intravenous remdesivir, a combination of lopinavir and ritonavir, and also with convalescent plasma therapy (Cao et al 2020, Grein et al 2020, and Shen et al 2020) . Convalescent plasma therapy is considered very beneficial initially and still being considered by many groups (Chen et al 2020, Zhang et al 2020, and Kai Duan et al 2020). However, still there is a key question about durability and longevity of immunity in recovered patients. Therefore, our aim in this study was to analyse immune markers in COVID-19 patients with severe disease and in recovered patients (who had recovered from the mild form of the disease and considered for convalescent plasma donations). Here we described novel observation that increased activated monocytes, T cells, and low APRIL and BAFFR expressing B cells are present in COVID-19 patients and also have sustained existence of these markers in COPLA donors even after 3 weeks of recovery. The mean age, gender, and body mass index (BMI) were comparable between the groups. The COVID RT-PCR+ve patients had severe disease with a high respiratory rate (34.47 ± 2.5), low O2 saturation (85 ± 4.03), low baseline PaO2/FiO2 ratio (162.92 ± 13.77), and X-ray changes (Table.1 ). Recovered patients (with history of mild infection) who were RT-PCR negative and in whom at least 14 days had passed after recovery were considered for convalescent plasma donation (COPLA donors) and they formed the second group. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Principal component analysis revealed that three groups have differential expression preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233668 doi: medRxiv preprint and MIP1a, but, there was a significant surge of MCSF and IL-18 which was not observed in COVID-19 patients . COVID-19 patients who did not survive for a week due to severe COVID19, showed significantly increased IL-6, IL-10, MIP3a, MIP1-a, Fractelkine, and VEGF-A (Fig. 1C ). Finally, correlation analysis showed that few plasma analytes were significantly correlated with clinical parameters in COVID-19 patients. Increase in IL-6, MIP1β, and Leptin but decreased concentrations of Fractelkine was significantly correlated with FiO2 concentration and SOFA score (Fig. 1D ). The total circulating monocyte population was increased in severe patients and There was no significant difference in immune profile after a week in patients except classical monocytes increased in circulation (data not shown). However, in COPLA donors, after three weeks of recovery, we have observed the classical monocyte compartment was significantly increased with no change in HLA-DR but with sustained expression of CX3CR1 ( FIG. 2A-B ). In COVID-19 patients, increase in total monocytes were significantly correlated with increase in BMI and respiratory rates. However, intermediate monocyte was significantly increased with increasing age and Fio2 levels (FIG. 2C) . All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020. 11.17.20233668 doi: medRxiv preprint In patients, the CD3 + T cell compartment was not significantly different from healthy subjects, however, the ratio of CD4/CD8+T cells was skewed in patients towards more towards CD4 + T cells. T cells, when further were compartmentalized on the basis of CD45 RA, CCR7, and CD27expression, into naïve, effector, central memory and effector memory T cells, it was observed that in patients, CD4 naïve cells were reduced but central memory T cells was increased. However, in CD8 T cells compartment, naïve, effector, central, and effector memory subsets were increased compared to healthy (Fig. 3) . COPLA donors did not show different numbers of CD4/CD8 T cells than healthy controls, however, they still had greater expression of effector and central memory but reduced effector memory compartment of CD8 T cells. In COVID-19 patients, increase in BMI and PLT were negatively correlated with effector, effector memory and central memory CD8 + T cells (Fig. 3D) . We have also observed that in patients, increased effector CD8 +ve T but not CD4 +ve Tcells could secrete IFNγ , IL-17 and IL-2 upon LPS stimulation in vitro (Fig.4) Total B cells were reduced in COVID patients, however, it was not significantly different from healthy subjects ( Correlation analysis also revealed decreased memory B cells, APRIL and BAFFR expression was strongly correlated with SOFA Score and age of COVID-19 patients ( Fig.5 D) . Analysis of plasma analytes using cytokine bead assay revealed the involvement of inflammatory monocytes by raising the levels of MIPs, MIF, and MCP1 in COVID-19 patients than healthy controls. Indeed, most of the pro-inflammatory cytokines such as IL-2, IL-1b, Il-6 IFN-γ, and IP-10 were expressed similar to the range in healthy controls. Only four patients who did not survive for a week had marginally increased All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 18, 2020. Increased plasma monocyte chemotactic protein-1 (MCP-1) and CCR2 on monocytes in COVID-19 patients and COPLA donors strongly suggest that SARSCOV2 specifically target this population and is responsible for keeping All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 18, 2020. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233668 doi: medRxiv preprint 1 1 Two consecutive negative test results of Real-time reverse transcriptase Polymerase chain reaction (RT-PCR) were done 24 hours apart from combined oral and nasopharyngeal swab for SARS CoV-2 for donation consideration. We collected demographic data, symptoms, and clinical signs from the medical records. Laboratory tests were conducted for serum protein, CBC; transfusiontransmitted infections (hepatitis B virus, hepatitis C virus, HIV, malaria, and syphilis), blood grouping, and IgG antibody against SARS CoV-2. The Monocytes, T-cells, B cells, and Tregs were characterized in whole blood. 100 µl of whole blood sample was stored in 700 µl of FACS Lysing solution (BD Pharmingen, USA) and was stored in -80 C for further use. Using specific antibodies against surface and intracellular markers labelled with different fluorochromesblood mononuclear cells were characterized. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233668 doi: medRxiv preprint All samples were processed on single day in one batch to avoid any batch to batch processing variation. FACS Lysed samples were thawed in 37 C water bath for a minute and immediately centrifuged and washed twice with 1x PBS containing 0.5% BSA with 0.1% Sodium Azide at 400g for 3 minutes at room temperature. After two washes, cell pellet was stained for surface expressing markers by incubating with appropriate cell specific antibodies for 30 minutes at room temperature in the dark. After incubation, cells were washed with 1x PBS containing 0.5% BSA with 0.1% Sodium Azide and spun at 400g for 3 minutes to discard the supernatant. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233668 doi: medRxiv preprint and Pharmingen, USA), incubated for 25-30 minutes followed by washing with PBS and fixing the cells in 0.1 % PFA before acquiring on a BD Verse flow cytometer. Data was analyzed using FlowJo software version 10. Continuous variables were expressed as mean (SD) or median (range) and compared by student T-test or Mann-Whitney U test as appropriate. The categorical data were analyzed using Chi-Square or Fisher's exact test. To compare pre-and post-values, a paired t-test or Wilcoxon signed-rank test was used. Pearson correlation was calculated with respect to many clinical parameters. Ramirez and Julia Carracedo (2011) and monocytes were significantly correlating with higher BMI and respiratory rate. Decreased CCR2 expression was also correlating with higher respiratory rate in COVID-19 patients. Increased HLADR on intermediate and non-classical monocytes All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233668 doi: medRxiv preprint and IL4RA expression was correlating with increased age, FiO2 and Pao2/FIO2levels. Error short bars in the graph shows the mean ± SEM. P < 0.05 is considered significant. r is representing correlation coefficient. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 18, 2020. ; https://doi.org/10.1101/2020.11.17.20233668 doi: medRxiv preprint Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Transmission Potential of Asymptomatic and Paucisymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections: A 3-Family Cluster Study in China Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome Clinical infectious diseases: an official publication of the Infectious Diseases Society of America A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19 Compassionate Use of Remdesivir for Patients with Severe Covid-19 Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma Convalescent plasma as a potential therapy for COVID-19 Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection Effectiveness of convalescent plasma therapy in severe COVID-19 patients Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic A Dynamic Immune Response Shapes COVID-19 Progression Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing Nomenclature of monocytes and dendritic cells in blood